Tanaka Growth Fund TGFRX

Medalist Rating as of | See Tanaka Investment Hub
  • NAV / 1-Day Return 65.61  /  −0.85 %
  • Total Assets 39.2M
  • Adj. Expense Ratio
    1.950%
  • Expense Ratio 1.950%
  • Distribution Fee Level High
  • Share Class Type No Load
  • Category Large Growth
  • Investment Style Mid Growth
  • Min. Initial Investment 2,000
  • Status Open
  • TTM Yield 0.00
  • Turnover 23%

USD | NAV as of Jul 11, 2026 | 1-Day Return as of Jul 11, 2026, 12:11 AM GMT+0

Morningstar’s Analysis TGFRX

Will TGFRX outperform in the future?

Get our overall rating based on a fundamental assessment of the pillars below.

null Morningstar Automated Analysis

Morningstar Automated Analysis

Summary

Tanaka Growth holds a quantitatively derived Neutral Morningstar Medalist Rating. The rating suggests the model does not express a clear expectation of outperformance or underperformance relative to peers over a full market cycle.

Rated on Published on

Unlock our full analysis with Morningstar Investor

Portfolio Holdings TGFRX

  • Current Portfolio Date
  • Equity Holdings
  • Bond Holdings
  • Other Holdings
  • % Assets in Top 10 Holdings 55.8
Top 10 Holdings
% Portfolio Weight
Market Value USD
Sector

Cash & Cash Equivalents

14.08 5M
Cash and Equivalents

United States Antimony Corp

7.83 3M
Basic Materials

Nuvation Bio Inc Ordinary Shares - Class A

7.73 3M
Healthcare

NVIDIA Corp

6.66 2M
Technology

NexGen Energy Ltd

6.57 2M
Energy

Aura Minerals Inc

6.43 2M
Basic Materials

Corcept Therapeutics Inc

5.03 2M
Healthcare

Apple Inc

4.67 2M
Technology

Applied Materials Inc

3.88 1M
Technology

Intellia Therapeutics Inc

3.71 1M
Healthcare

Sponsor Center